After building the science and market for its MenaQ7 vitamin K2 ingredient in the dietary supplement space, NattoPharma is spinning off a new pharmaceutical entity to take K2 into targeted therapeutics.
Israel-based microbiome firm BiomX says the acquisition of RondinX will fortify the company’s bacterial target discovery capabilities and supports its product development pipeline.
Mythocondro, a non-animal chondroitin sulfate (CS) marketed by Italian firm Gnosis has received novel food approval in the European Union (EU), the company has confirmed.
The IPA World Congress + Probiota 2018 program will see a mix of cutting edge microbiome research, probiotic and prebiotic science, consumer trends and innovation insights as top global experts come together to discuss the future of the probiotic, prebiotic...
A PhD student at Harper Adams University in the UK has successfully increased the level of long chain omega-3 while reducing the level of saturated fatty acids in cheese, and producing the same the taste, by feeding microalgae to cows.
